Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
76.94
-1.12 (-1.43%)
At close: May 22, 2026, 4:00 PM EDT
76.42
-0.52 (-0.67%)
After-hours: May 22, 2026, 7:38 PM EDT

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Research and Development Revenue
9.74M8.69M3.47M
Research and Development Revenue Growth
12.18%150.03%-13.80%
Milestone Revenue
-79.35M15.00M
Milestone Revenue Growth
-429.02%328.57%
Revenue (Total)
105.82M88.04M18.47M
Revenue (Total) Growth
20.19%376.56%145.34%
Updated May 5, 2026. Data Source: Fiscal.ai.